• slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
  • slidebg1
04
04/18
NEWS
Chiesi Group receives the European Marketing Authorisation for Lamzede®...
  Lamzede® (velmanase alfa) is the first enzyme replacement therapy for the treatment of non-neurological...
PRESS RELEASE
Chiesi receives the Top Employer 2018 certification for the sixth successive...
Barcelona, February 1, 2018. For six year in arrow, the commitment of Chiesi in the field of Human Resources has been rewarded...
Working At Chiesi